1.Two cases of multiple brain abscess associated with bacterial meninitis in neonate.
Jin Jea KIM ; Heung Keun OH ; Hyun Sung PARK ; Chang Ok SOH ; Jin Young JUNG
Journal of the Korean Pediatric Society 1993;36(10):1466-1470
We experienced nutiple brain abscess in two neonates. Diagnosis was made CT scan, Which revealed multiple ring-like enhancing leason in both frontoparietal and left posterior parietal cerebral parenchyme. Therapy was consisted of systemic antibiotic treatment and CSF V-P shunt operation due to complicated hydrocephalus. One neonate was died and the other neonate has been followed up due to convulsion and neurological sequale.
Brain Abscess*
;
Diagnosis
;
Humans
;
Hydrocephalus
;
Infant, Newborn*
;
Rabeprazole
;
Seizures
;
Tomography, X-Ray Computed
2.Temporary Percutaneous Endoscopic Gastrojejunostomy : A case report.
Jea Heung PARK ; Hyun Joo SOHN ; Ji Sang PARK
Journal of the Korean Academy of Rehabilitation Medicine 2006;30(3):282-285
We reported a 56-year-old man who presented with vagus nerve injury after deep laceration in the neck. During being treated the neck insult, he was performed pyloplasty and vagotomy and used total parenteral nutrition due to peptic ulcer perforation and panperitonitis. He suffered from swallowing difficulty and underwent percutaneous endoscopic gastrostomy placement. As formerly, recurrent gastroesophageal reflux symptoms and gastric feeding intolerance were developed. We fixed a transgastrostomal jejunal tube in jejunum through the gastric stoma. The gastroeophageal reflux and feeding intolerance did not recur. After 30 days later, jejunal tube was removed, nutritional support was replaced by gastric tube. We were able to provide a temporary nutritional bridge with percutaneous endoscopic gastrojejunostomy placement for patients who suffered from dysphagia.
Deglutition
;
Deglutition Disorders
;
Gastric Bypass*
;
Gastroesophageal Reflux
;
Gastrostomy
;
Humans
;
Jejunum
;
Lacerations
;
Middle Aged
;
Neck
;
Nutritional Support
;
Parenteral Nutrition, Total
;
Peptic Ulcer Perforation
;
Vagotomy
;
Vagus Nerve Injuries
3.Hemolytic-Uremic Syndrome Associated with Bloody Diarrhea.
Jung Sim KIM ; Eun Jung PARK ; So Hee CHUNG ; See Hwan KO ; Mee Ryung UHM ; Moon Su PARK ; Heung Jea LEE ; Dong Kyu JIN
Journal of the Korean Society of Pediatric Nephrology 1997;1(2):170-175
The authors analysed 2,653 cases of transthoracic fine needle aspiration cytology of the lung to evaluate the diagnostic accuracy and its limitation. A comparison was made between the original cytologic and the final histologic diagnoses on 1,149 cases from 1,074 patients. A diagnosis of malignancy was established in 38.3% benign in 48.1%, atypical lesion in 2.3%, and inadequate one in 11.9% of the cases. Statistical data on cytologic diagnoses were as follows; specificity 98.9%: sensitivity of procedure, 76.8%: sensitivity of diagnosis, 95.5%: false positive 5 cases: false negative 18 cases: predictive value for malignancy, 98.8%: predictive value for benign lesion, 79.5%: overall diagnostic efficiency, 87.5%: typing accuracy in malignant tumor, 80%.
Biopsy, Fine-Needle
;
Diagnosis
;
Diarrhea*
;
Hemolytic-Uremic Syndrome*
;
Humans
;
Lung
;
Sensitivity and Specificity
4.Responsiveness of CPT-11 in Respect to hMLH1 and hMSH2 Protein Expression in the Primary Colorectal Cancer.
In Ja PARK ; Hee Cheol KIM ; Chang Sik YU ; Heung Moon CHANG ; Jea Hwan LEE ; Jong Hoon KIM ; Tae Won KIM ; Jung Sun KIM ; Jin Cheon KIM
Cancer Research and Treatment 2004;36(6):360-366
PURPOSE: The aim of this study was to evaluate the responsiveness to CPT-11 with respect to hMLH1 and hMSH2 protein expressions in primary colorectal tumors. MATERIAL AND METHODS: 91 patients with colorectal cancer treated having undergone surgery and postoperative CPT-11-based adjuvant chemotherapy, between 1997 and 2002, were prospectively recruited. Tumor samples were immunohistochemically analyzed for the expressions of hMLH1, hMSH2, p53 and CEA proteins. RESULTS: Of the 91 tumors, 6 (6.6%) and 4 (4.4%) showed loss of hMLH1 and hMSH2 protein expressions, respectively. The response rate of patients with tumors not expressing either hMLH1 or hMSH2 was higher than that of those expressing either of these proteins (p=0.026). Patients with tumors not expressing hMLH1 showed a significantly better response to CPT-11 (p=0.04). The responsiveness was not associated with the expressions of hMSH2, p53 or CEA. There were no correlations between drug toxicity and the expressions of hMLH1, hMSH2 or p53. The overall survival was better in patients responsive to CPT-11-based chemotherapy compared to non-responders. CONCLUSION: The immunohistochemical determination of loss of hMLH1 and hMSH2 expressions may be used in determining the responsiveness to CPT-11-based chemotherapy. Our results suggest that hMLH1 protein expression may be a predictor for CPT-11 responsiveness in patients with colorectal cancer.
Chemotherapy, Adjuvant
;
Colorectal Neoplasms*
;
Drug Therapy
;
Drug-Related Side Effects and Adverse Reactions
;
Humans
;
Prospective Studies